Hand-foot syndrome and seborrheic dermatitis-like rash induced by sunitinib in a patient with advanced renal cell carcinoma

被引：46
作者：
Tsai, Kun-Ying [1 ]
Yang, Chih-Hsun
Kuo, Tseng-tong
Hong, Hong-Shang
Chang, John W. C.
机构：
[1] Chang Gung Mem Hosp & Univ, Dept Dermatol, Taipei, Taiwan
[2] Chang Gung Mem Hosp & Univ, Dept Pathol, Taipei, Taiwan
[3] Chang Gung Mem Hosp & Univ, Dept Hematol Oncol, Taipei, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 36期
关键词：
D O I：
10.1200/JCO.2006.08.6868
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：5786 / 5788
页数：4
相关论文
共 14 条
[1]   Safety and pharmacokinetics of the dual action Raf kinase and vascular endothelial growth factor receptor inhibitor, BAY 43-9006, in patients with advanced, refractory solid tumors [J].
Clark, JW ;
Eder, JP ;
Ryan, D ;
Lathia, C ;
Lenz, HJ .
CLINICAL CANCER RESEARCH, 2005, 11 (15) :5472-5480
[2]   PLATELET-DERIVED GROWTH-FACTOR IS A POTENT BIOLOGIC RESPONSE MODIFIER OF T-CELLS [J].
DAYNES, RA ;
DOWELL, T ;
ARANEO, BA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (06) :1323-1333
[3]   Combined inhibition of VEGF- and PDGF-signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms [J].
Erber, R ;
Thurnher, A ;
Katsen, AD ;
Groth, G ;
Kerger, H ;
Hammes, HP ;
Menger, MD ;
Ullrich, A ;
Vajkoczy, P .
FASEB JOURNAL, 2003, 17 (15) :338-340
[4]   Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer [J].
Faivre, S ;
Delbaldo, C ;
Vera, K ;
Robert, C ;
Lozahic, S ;
Lassau, N ;
Bello, C ;
Deprimo, S ;
Brega, A ;
Massimini, G ;
Armand, JP ;
Scigalla, P ;
Raymond, E .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (01) :25-35
[5]   Seborrheic dermatitis [J].
Gupta, AK ;
Bluhm, R .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2004, 18 (01) :13-26
[6]   Dermatologic side effects of thalidomide in patients with multiple myeloma [J].
Hall, VC ;
El-Azhary, RA ;
Bouwhuis, S ;
Rajkumar, SV .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 48 (04) :548-552
[7]  
Lassere Yvonne, 2004, Eur J Oncol Nurs, V8 Suppl 1, pS31, DOI 10.1016/j.ejon.2004.06.007
[8]   Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma [J].
Negrier, S ;
Escudier, B ;
Lasset, C ;
Douillard, JY ;
Savary, J ;
Chevreau, C ;
Ravaud, A ;
Mercatello, A ;
Peny, J ;
Mousseau, M ;
Philip, T ;
Tursz, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (18) :1272-1278
[9]   A novel T cell receptor transgenic animal model of seborrheic dermatitis-like skin disease [J].
Oble, DA ;
Collett, E ;
Hsieh, M ;
Ambjorn, M ;
Law, J ;
Dutz, J ;
Teh, HS .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 124 (01) :151-159
[10]  
Ritchie A, 1999, LANCET, V353, P14
12